ORLANDO -- Fentanyl buccal tablets
effectively and safely relieved breakthrough cancer pain in opioid-tolerant cancer patients, according to a multicenter open-label trial presented at the annual meeting of the American Academy of Pain Medicine.
Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets
for the treatment of oropharyngeal candidiasis (OPC), more commonly known as thrush, in adults and children age 16 and older.
today announced that its development partner BioAlliance Pharma SA presented Phase III study results for miconazole Lauriad mucoadhesive buccal tablets
(MBT) that demonstrate noninferiority to clotrimazole troches for oropharyngeal candidiasis (OPC), an opportunistic infection of the mouth and throat.
Cephalon markets fentanyl buccal tablets
under the trade name Fentora, an opioid agonist that is a schedule II controlled substance.
The lawsuit is based upon an Abbreviated New Drug Application (ANDA) filed by Watson seeking FDA approval for a generic equivalent of fentanyl buccal tablets
to be sold in the United States.
Results of preliminary research show that fentanyl effervescent buccal tablets
(FEBT) may provide rapid-onset analgesia in patients with cancer-related breakthrough pain, which is usually treated with a short-acting opioid.
NASDAQ: IPXL) today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora[R] (fentanyl buccal tablets
, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).
NYSE: WPI), today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora (fentanyl buccal tablets
C-II) infringes United States Patent No.
NYSE: WPI), today announced that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora (fentanyl buccal tablets
C-II) does not infringe United States Patent Nos.
has received approval from the United States Food and Drug Administration (FDA) for Fentanyl Buccal tablets
, USP, in the 0.
The additional results from BioAlliance Pharma's pivotal Phase III study with miconazole Lauriad([R]) mucoadhesive buccal tablets
(MBT) demonstrated comparable efficacy and safety profile to that of clotrimazole troches (administered five times per day) for oropharyngeal candidiasis (OPC), in HIV-positive patients in 40 sites in the United States, Canada and South Africa.
Watson's Fentanyl Citrate Buccal tablets
are a generic version of Cephalon's Fentora.